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Abstract
Balkan endemic nephropathy (BEN), a disease characterized by progressive renal fibrosis in human patients, has been associated with
exposure to ochratoxin A (OTA). This mycotoxin is a frequent contaminant of human and animal food products, and is toxic to all animal
species tested. OTA predominantly affects the kidney and is known to accumulate in the proximal tubule (PT). The induction of oxidative
stress is implicated in the toxicity of this mycotoxin.
In the present study, primary rat PT cells and LLC-PK1 cells, which express characteristics of the PT, were used to investigate the OTA-
mediated oxidative stress response. OTA exposure of these cells resulted in a concentration-dependent elevation of reactive oxygen species
(ROS) levels, depletion of cellular glutathione (GSH) levels and an increase in the formation of 8-oxoguanine.
The OTA-induced ROS response was significantly reduced following treatment with a-tocopherol (TOCO). However, this chain-braking
anti-oxidant did not reduce the cytotoxicity of OTA and was unable to prevent the depletion of total GSH levels in OTA-exposed cells. In
contrast, pre-incubation of the cell with N-acetyl-L-cysteine (NAC) completely prevented the OTA-induced increase in ROS levels as well as
the formation of 8-oxoguanine and completely protected against the cytotoxicity of OTA. In addition, NAC treatment also limited the GSH
depletion in OTA-exposed PT- and LLC-PK1 cells.
From these data, we conclude that oxidative stress contributes to the tubular toxicity of OTA. Subsequently, cellular GSH levels play a
pivotal role in limiting the short-term toxicity of this mycotoxin in renal tubular cells.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Ochratoxin A (OTA) is produced by Aspergillus and
Penicillium strains, and is a frequent contaminant of feed
and foodstuffs. Epidemiological studies associate OTA with
Balkan endemic nephropathy (BEN), a progressive renal
fibrosis, and tumors of the urinary tract. However, the
etiology of the disease still remains unclear [1–3]. In
animals, OTA was shown to induce a tubulo-interstitial
nephropathy similar to BEN [4–6] as well as renal adenoma
and carcinoma [7]. Other toxic effects associated with OTA
include immunosuppression, hepatotoxicity and teratogenic-
ity (for a review, see Refs. [8–12]).
OTA is known to affect multiple sites of the nephron:
acute exposure mainly affects the postproximal parts, while
chronic exposure leads predominantly to damage of the
proximal tubule (PT) [13]. The exact mechanism of OTA
toxicity has not been elucidated as of yet. OTA contains a
chlorinated dihydroisocoumarin moiety linked to L-phenyl-
alanine. The observed inhibition of protein synthesis by
OTA [14] results from competition with phenylalanine
during the aminoacetylation reaction of phenylalanine–
tRNA [12]. The inhibition of protein synthesis is thought
to underlie most toxic effects of OTA, but protein inhibition
alone cannot explain the diverse but apparent site-specific
toxic effects. Several studies propose the involvement of
oxidative stress to the toxicity of OTA [5,15–17]. Initially,
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Rahimtula et al. [17] have shown that OTA induces lipid
peroxidation (LPO) in subcellular fractions. Further evi-
dence showing that OTA is a potent pro-oxidant was
provided by Belmadani et al. [15] who reported that OTA
induced LPO in primary cultures of brain cells. In addition,
the formation of reactive oxygen species (ROS) was sig-
nificantly increased after exposure of foetal rat telencepha-
lon cells to high OTA concentrations [18]. The kidney is a
prominent site for intense oxidative processes in the body
and ROS play an important role in the pathogenesis of a
variety of renal diseases [19]. Thus, we investigated the
relation between the OTA-induced oxidative response and
toxicity in its main target cells, renal PT cells, using
primary rat proximal tubular cells (PT cells) and continuous
proximal tubular cells (LLC-PK1). Primary cells resemble
the in vivo PT cell closely by expressing PT-specific
functions including phase I and II biotransformation and
organic anion and cation transport [20]. LLC-PK1 cells are
widely used as in vitro model of cultured tubular epithelial
cells, as they have retained several characteristics of the PT
cell [21]. In contrast to the primary cells, the LLC-PK1
cells have lost some differentiated functions, including
organic anion transport [22]. The OTA-induced stress
response was monitored at several levels in these cells, as
ROS can attack almost any cellular structure or molecule,
including membrane lipids, proteins and DNA [23,24]. The
effects of exposure of the cells to OTA on ROS production
and cell viability were assessed with respect to concen-
tration- and time-dependency. Furthermore, the effects of
the mycotoxin on cellular glutathione (GSH) levels and the
formation of 8-oxoguanine were investigated. The estab-
lished anti-oxidants a-tocopherol (TOCO) and N-acetyl-L-
cysteine (NAC) were used to determine the contribution of
oxidative stress to DNA damage and cytotoxicity induced
by OTA.
2. Materials and methods
2.1. Materials
Dimethylthiazol diphenyl tetrazolium bromide (MTT),
NAC, OTA and TOCO were obtained from Sigma (St.
Louis, MO, USA). 2V,7V-Dichlorodihydrofluorescein diac-
etate (H2DCF-DA) was obtained from Molecular Probes
(Leiden, The Netherlands). DMEM/F12 and medium 199
culture media and supplement G (insulin 10 mg/l, transferrin
5.5 mg/l, sodium-selenite 6.7 Ag/l) were obtained from Life
Technologies (Breda, The Netherlands). All other chemicals
were of analytical grade and purchased from Sigma (St.
Louis, MO, USA). OTA, TOCO and H2DCF-DA were
dissolved in DMSO and diluted in culture medium to the
concentrations described in the text. NAC was diluted in
ethanol/H2O (1:1; v/v). Solvent concentrations were 0.1%
(v/v) unless specified otherwise. OTA dilutions were pre-
pared in serum-free medium.
2.2. Cell culture
2.2.1. Isolation of rat PT cells
Rat PT cells were isolated as described previously [20].
Cell yield was 30–50 106 cells/rat and cell viability was
routinely higher than 70% as judged by trypan blue exclu-
sion. Cells were seeded on collagen (rat tail type IV) pre-
coated 60 mm culture dishes (1106 cells/dish) in culture
medium containing serum (10% FCS) for 24 h. After 24 h,
non-attached cells were removed, pelleted and re-plated (in
the same culture dishes) in fresh serum-free culture medium
to increase attachment efficiency. Medium was then
changed every 3 days with serum-free DMEM/F12 supple-
mented with 10 mg/l insulin, 5.5 mg/l transferrin, 6.7 Ag/ml
sodium selenite (supplement G; 1 concentrated), 10 U/ml
penicillin and 10 Ag/ml streptomycin. OTA, H2DCF-DA
and TOCO were dissolved in DMSO; NAC was dissolved
in H2O/ethanol (1:1, v/v). The stock solutions were further
diluted in culture medium, so that solvent concentrations
never exceeded 0.1% (v/v).
2.2.2. LLC-PK1 cells
LLC-PK1 cells, obtained from ATCC (number CL-101)
were routinely seeded at 4 105 cells/75 cm2 flask and were
subcultured every 6–7 days. Two days before experiments,
cells were plated at a density of 2.7 104 cells/cm2 culture
area in medium 199 supplemented with 5% FCS, 2 mM L-
glutamine, 100 U/ml penicillin and 100 Ag/ml streptomycin.
Cells were maintained in a 5% CO2 humidified atmosphere
at 37 jC.
2.3. Determination of ROS production
Cells were seeded in 96-well culture plates at 1104 cells/
well and allowed to grow for 48 h. In the dose-response
experiments, cells were then incubated for 2 h at 37 jC cells
in serum-free medium containing 20 AM H2DCF-DA. After
aspiration of H2DCF-DA, the cells were rinsed once and were
subsequently exposed to increasing concentrations of OTA
(0–200 AM) in serum- and phenol red-free medium. ROS
production wasmeasured after 24 h incubation on a Cytofluor
2300 (Fluorescence Measurement System, Millipore, Bed-
ford, MA, USA) with an excitation wavelength of 485 nm
and an emission wavelength of 538 nm. In the experiments
with the anti-oxidants, cells were incubated 48 h after plating
with increasing concentrations of TOCO (0–12.5 AM) or
NAC (0–4 mM). Following the 24-h pre-incubation period,
the cells were treated with H2DCF-DA as described above.
After removal of H2DCF-DA, cells were exposed to a fixed
OTA concentration (100 AM) in the presence of increasing
concentrations of TOCO or NAC. The ROS levels were
determined 24 h later as described above. The incubation
volumes were 50 Al/well unless specified otherwise. Relative
ROS production was expressed as the ratio of fluorescence of
the treated samples over the response in the appropriate
controls [(fluorescencetreatment/fluorescencecontrol)100%].
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2.4. Determination of cell viability
Cell viability was assessed by measuring the reduction of
MTT to formazan by the mitochondrial enzyme succinate
dehydrogenase [25]. Cells were seeded on 96-well plates at
1104 cells/well. In the dose-response experiments, cells
were exposed to increasing concentrations of OTA (0–200
AM) for 4 and 24 h. Then 0.6 mg/ml MTT solution (final
concentration in medium; 3 mg/ml stock dissolved in PBS)
was added to the wells. Plates were then incubated for 2 h at
37 jC in a humidified atmosphere. The reaction was
terminated by discarding the incubation solutions followed
by dissolving the formazan product in 50 Al acidic isopro-
panol (containing 0.1 M HCl). Absorbance at 595 nm was
determined on a Biorad 3550 microplate reader (Biorad,
Veenendaal, The Netherlands).
In the experiments with the anti-oxidants, cells were
incubated 48 h after plating with increasing concentrations
of TOCO (0–12.5 AM) or NAC (0–4 mM). Following the
24-h pre-incubation period, cells were exposed to a fixed
OTA concentration (100 AM) in the presence of increasing
concentrations of TOCO or NAC. Cell viability was deter-
mined 24 h later as described above. The incubation
volumes were 50 Al/well unless specified otherwise.
Cell viability was expressed as the relative formazan
formation in treated samples as compared to that in solvent-
treated controls [(A595 treated cells/A595 of appropriate
control)100%, after correction for background absorbance].
IC50 values, defined as the concentrations inducing 50%
loss of cell viability, were estimated from the figures. IC50
values (24 h OTA incubation) were calculated after fitting
the cell viability data with Slide Write plus software,
version 4.0 (BIS Netherlands, Ridderkerk, The Nether-
lands).
2.5. Determination of cellular GSH levels
Total cellular GSH (reduced GSH, GSSG and GSSR)
measurements were based on the method described by
Griffith [26]. Cells were seeded at 5 104 cells/well in
24-well plates (for rat PT cells, the plates were coated with
collagen type I as previously described [20]). The (pre-)
incubation volumes were 500 Al. Cells were either pre-
incubated for 24 h with solvent (0.1% DMSO or ethanol), 5
AM TOCO, 2 mM NAC (PT cells) or 4 mM NAC (LLC-
PK1). Initially, for measurements of solvent controls, cells
were treated with either 0.1% (v/v) DMSO (vehicle for
TOCO) or 0.1% (v/v) ethanol/ddH2O [1:1] (vehicle for
NAC) and results interpreted independently. However, rep-
licate measurements (two groups of triplicate measure-
ments) showed that these solvent control groups did not
differ significantly and are thus presented as one group
(solvent in Table 1). Following the pre-incubation period,
cells were exposed to OTA (0, 6.25 or 100 AM). After 24 h,
the incubation medium was aspirated and cells were har-
vested in 100 Al cold harvest buffer [Triton X-100 0.05%
(w/v), EDTA 0.05 mM in PBS]. The amount of protein was
determined in 10 Al of this suspension, while 10 Al sulfo-
salicylic acid 25% (w/v) was added to the remaining 90 Al
sample. After centrifugation of the samples (12,000 g, 5
min 4 jC), 20 Al triethanolamine (T-1377, Sigma) was
added. GSH levels were determined in a mixture contain-
ing 5.3 mM NADPH and 0.6 mM 5-5Vdithio-bis (2-nitro-
benzoic acid) [DTNB]. After incubation for 5 min at
30 jC, 25 Al sample or GSH standard (0, 0.5, 1.0, 2.0
and 3.0 mg/ml) was added. The reaction was initiated with
glutathione reductase (0.5 U/sample) and the increase in
absorption at 412 nm and 30 jC was determined. Specific
activity was calculated by comparison to a standard curve.
Activity was expressed as nanomoles per milligram total
cellular protein.
2.6. Detection of OTA-induced oxidative DNA damage
LLC-PK1 cells were seeded at 5 104 cells/chamber on
LabTek 8-chamber slides (Nalgene, cat. no. 177445, Life
Technologies, Breda, The Netherlands) 2 days before the
start of the experiment. As reference, cells were exposed to
methylene blue (2 mM; MB) for 1 h followed by 30 min
exposure to ambient light, a treatment known to generate
primarily 8-oxoguanine adducts [27]. For experiments
Table 1
The effect of anti-oxidant treatment on GSH levels (nmol/mg protein) in rat
PT- and LLC-PK1 cells exposed to OTA for 4 and 24 h
OTA Anti- PT cells LLC-PK1
oxidant
4 h OTA 24 h OTA 4 h OTA 24 h OTA
OTA 0 lM
Solventa 3.2F 1.3 1.5F 0.4 22.9F 3.3 15.8F 2.1
TOCO 4.1F 0.7 2.0F 0.9 26.6F 2.4 23.8F 2.1 *
NAC 28.2F 4.4 * 21.1F 2.0 * 26.8F 2.5 16.5F 2.3
OTA 6.25 lM
Solventa 3.7F 1.2 2.0F 2.3 20.4F 4.0 12.2F 6.8
TOCO 4.9F 1.4 1.9F 1.3 23.5F 3.7 9.0F 3.8
NAC 38.2F 4.5 *,# 15.5F 3.9 *,# 31.1F 4.0# 24.1F 6.5
OTA 100 lM
Solventa 5.5F 1.5 ND 18.2F 2.0 3.4F 2.3 *,#
TOCO 5.2F 1.2 ND 21.6F 1.7 5.9F 1.2 *
NAC 30.4F 4.1 *,§ 3.8F 0.9 *,§ 28.4F 2.5§ 8.3F 8.8 *
Cells were pre-incubated for 24 h with 5 AM TOCO, 2 mM NAC (PT cells)
or 4 mM (LLC-PK1) NAC. Following pre-incubation with the anti-oxidant,
OTAwas added and GSH levels were determined 4 and 24 h later. The data
represent meansF S.D. from triplicate measurements from at least two
independent experiments. Symbols indicate significant difference
( P< 0.05). ND: below limit of detection ( < 30 pmol/mg protein).
a Solvent-treated cells refer to cells treated with 0.1% (v/v) DMSO
(vehicle for TOCO) or 0.1% (v/v) ethanol/ddH2O [1:1] (vehicle for NAC).
* Significantly different from GSH levels in non-exposed (0 AM OTA)
solvent-treated cells.
# Significantly different GSH levels in solvent-treated cells exposed to
6.25 AM OTA.
§ Significantly different GSH levels in solvent-treated cells exposed to
100 AM OTA.
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involving OTA, LLC-PK1 cells were either pre-incubated
with solvent (0.1% EtOH) or with 4 mM NAC for 24 h.
Cells were then exposed to 15 AM OTA for 4 and 24 h. The
cells were fixed using cold 4% paraformaldehyde for 30
min. The Biotrin OxyDNA assay (Biotrin, cat. no. BIO81-
DNA, Dublin, Ireland) was used to detect the formation of
8-oxyguanine adducts. The Biotrin OxyDNA assay was
performed according to the manufacturers’ instructions.
Micrographs were taken immediately following the experi-
ments using a fluorescence microscope (Olympus BX60,
Hamburg, Germany; with a U-MNB fluorescence filter
wheel, excitation wavelength between 470 and 490 nm,
emission wavelength 520 and 550 nm, magnification  20).
2.7. Protein determination
Total cellular protein was determined according to the
method described by Lowry et al. [28].
2.8. Statistical analysis
Significance of differences between different data groups
was first determined using a one-way ANOVA analysis
within a study and then by t-test pairwise comparison
(Bonferroni) of the groups of data using SYSTAT 8.0.
Differences were considered significant if P < 0.05.
3. Results
3.1. OTA-induced production of ROS
Fig. 1 shows that OTA concentration-dependently
induced the formation of ROS in both cell types. ROS
levels of primary rat PT cells were already significantly
elevated above the levels in solvent-treated (DMSO) con-
trols after 4 h of incubation with 12.5 AM OTA (Fig. 1A).
Fig. 1. OTA-induced ROS formation (A and B) and loss of cell viability (C and D) in primary PT cells and LLC-PK1. Primary PT (A and C) and LLC-PK1 cells
(B and D) were exposed to increasing concentrations of OTA and the ROS production (A and B) or cell viability (C and D) after 4 h (- -z- -) and 24 h (—.—)
of incubation with OTA was measured as described in the Materials and Methods section. The effect of serum (10% FCS) (—5—) on cell viability after
exposure of LLC-PK1 cells for 24 h to increasing concentrations of OTAwas also determined (D). The data are expressed as relative response as compared to
DMSO-treated controls (100%) and represent meansF S.D. from quadruplicate measurements from at least two independent experiments. The results of
statistical analysis are delineated in the text.
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After 24 h, the ROS production was significantly elevated
by OTA concentrations as low as 3.1 AM. In contrast, a
significant increase of ROS levels was observed following
exposure of continuous LLC-PK1 cells to a minimal effec-
tive concentration of 25 AM OTA after 4 h and 12.5 AM
OTA after 24 h, respectively (Fig. 1B). These data indicate
that this mycotoxin induces a ROS response in a concen-
tration- and time-dependent manner. The time-dependent
increase in ROS levels was more pronounced in LLC-PK1
cells as compared to the primary PT cells. In LLC-PK1 cells,
the formation of ROS induced by OTA concentrations >50
AM after 24 h incubation was significantly increased as
compared to the ROS response evoked by equimolar con-
centrations OTA after 4 h. In contrast, the ROS response to
OTA in rat PT cells after 24 h exposure did not differ
statistically from that after 4 h.
3.2. Cytotoxicity of OTA
The cell viability of primary rat PT cells incubated for
4 h with increasing concentrations of OTA in serum-free
medium decreased slightly, but this decrease was not
significant. However, 24 h OTA exposure in serum-free
medium clearly decreased cell viability in a concentration-
dependent manner (Fig. 1C). Loss of cell viability was
also time-dependent as viability after 24 h exposure to
OTA was significantly lower in PT cells than after 4 h
incubation for OTA concentrations of 12.5 AM and
higher.
This concentration- and time-dependent loss of cell
viability following OTA exposure was also observed in
LLC-PK1 cells. Interestingly, OTA-induced ROS produc-
tion clearly preceded the loss of cell viability in LLC-PK1
cells as cell viability was unaffected after 4 h incubation
with OTA, while a distinct ROS response was observed at
OTA concentrations exceeding 50 AM (Fig. 1D). In
contrast, cell viability was even slightly increased after
4 h exposure to high OTA concentrations (100 and 200
AM) in serum-free medium (P < 0.05 as compared to
vehicle-treated cells). However, exposure to increasing
concentrations of OTA for 24 h in serum-free medium
resulted in a loss of cell viability in LLC-PK1 cells (Fig.
1D). Loss of cell viability after 24 h was significantly
different from that after 4 h OTA incubation at 12.5 AM
and higher. However, the presence of serum in the incuba-
tion medium attenuated the cytotoxicity of OTA (data not
shown).
In serum-free medium, the calculated IC50 values follow-
ing 24 h exposure to OTA were approximately 83 and 25
AM for PT cells and LLC-PK1 cells, respectively, whereas in
the presence of 10% serum, the IC50 was approximately 50
AM. A concentration close to the IC50 values for both cell
types (100 AM for rat PT cells; 25 AM for LLC-PK1) were
chosen for successive experiments investigating the mech-
anism of OTA-mediated toxicity. The subsequent experi-
ments were performed in serum-free medium.
3.3. Influence of anti-oxidants on the OTA-induced ROS
response
Cells were pre-incubated for 24 h with the selected anti-
oxidative agent and subsequently challenged with OTA still
in the presence of the anti-oxidant. Treatment of rat PT cells
with several concentrations (1.56–12.5 AM) of TOCO
significantly decreased the OTA-induced ROS response
(Fig. 2A; hatched bars). Treatment with 6.25 and 12.5 AM
TOCO completely prevented the OTA-induced ROS
response. Similarly, the ROS production in rat PT cells
treated with 1, 2 and 4 mM NAC following exposure to
OTA was not statistically different from the basal ROS
levels in solvent-treated control cells (Fig. 2B; hatched
bars).
In LLC-PK1 cells treated with increasing concentrations
(1.56–12.5 AM) TOCO and exposed to OTA, the forma-
tion of ROS was not different from that in solvent-treated
cells, but was significantly in comparison with the
response in cells exposed to OTA alone (Fig. 2C; hatched
bars). Treatment of LLC-PK1 cells with 0.5–4 mM NAC
significantly decreased the OTA-mediated elevation of
ROS levels at all NAC concentrations tested, in a dose-
dependent manner. Treatment with 4 mM NAC appeared
to completely prevent loss of cell viability in cells exposed
to 25 AM OTA.
3.4. Influence of anti-oxidants on the OTA-induced loss of
cell viability
In addition to monitoring the effects of anti-oxidants on
the OTA-induced ROS response, the effects of TOCO and
NAC on the cell viability were determined. As depicted in
Fig. 2A (black bars), the treatment of the cells with TOCO
up to 12.5 AM could not prevent the OTA-induced loss of
cell viability in rat PT cells. In contrast, NAC treatment
showed a clear dose-dependent protective effect in rat PT
cells and at the tested concentrations between 0.5 and 4 mM
NAC (Fig. 2B; black bars).
Similarly as observed in PT cells, TOCO up to 12.5 AM
was unable to protect LLC-PK1 cells against the cytotoxicity
of OTA (Fig. 2C; black bars). In contrast, NAC treatment
provided a dose-dependent protection of LLC-PK1 cells
against the cytotoxicity of OTA (Fig. 2D; black bars). In
fact, the viability of the cells treated with 4 mM NAC
followed by exposure to OTA was not statistically different
from that of solvent-treated controls.
3.5. The role of GSH
Incubation with NAC strongly elevated GSH levels in
control PT cells, while TOCO incubation did not affect basal
GSH levels (Table 1). Exposure for 4 h to OTA did not
statistically affect GSH levels. The GSH levels of NAC-
treated PT cells were significantly higher after exposure to
6.25 and 100 AM OTA as compared to solvent- and TOCO-
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Fig. 2. The effect of TOCO and NAC on OTA-induced ROS response and loss of cell viability in renal tubular cells. Primary PT cells and LLC-PK1 cells were
pre-incubated for 24 h with indicated concentration of TOCO (A and C) or NAC (B and D). Following pre-incubation, OTAwas added and the production of
ROS (hatched bars) or the cell viability (MTT assay; black bars) was measured 24 h later. Cells were exposed to 100 AM OTA for ROS determinations (A–D).
For determination of the effect on cell viability (MTT assay), PT cells were exposed to 100 AM OTA (A and B), while LLC-PK1 cells were incubated with 25
AM OTA for 24 h (C and D). The OTA concentrations were chosen on the basis of the IC50 values in the respective cell types. The data represent the relative
response in treated cells as compared to the response in solvent-treated cells (100%). The results of the MTT assay are expressed as protection against the OTA-
induced loss of viability; therefore, the viability of the cells exposed to OTA alone (0 AM TOCO or NAC) was set at 0% (indicated in the figure as ‘‘a’’). The
data represent meansF S.D. of quadruplicate measurements from at least two independent experiments. * Significantly different from response in solvent-
treated cells ( P < 0.05). # Significantly different from the response in OTA-alone treated cells ( P < 0.05).
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treated cells (Table 1). TOCO treatment did affect the OTA-
induced GSH depletion.
A similar pattern was observed after 24 h exposure to
OTA, although the GSH levels were below the limit of
detection ( < 30 pmol/mg protein) after exposure to 100 AM
OTA, indicating significant depletion of GSH (Table 1).
Moreover, an evident decrease of GSH levels following 24 h
OTA exposure was observed in NAC-treated PT cells.
TOCO treatment did not result in preservation of the GSH
levels in OTA-exposed cells.
In LLC-PK1 cells, GSH levels were not statistically
affected after 4 h incubation with OTA, similarly as
observed in PT cells (Table 1). Table 1 shows that NAC
treatment resulted in significantly higher GSH levels after 4
h exposure to 6.25 and 100 AM OTA, as compared to
solvent-treated cells. TOCO treatment had no effect on the
GSH levels in OTA exposed LLC-PK1 cells.
The decrease in GSH levels in LLC-PK1 cells following
24 h OTA exposure was more pronounced at 100 AM OTA
than that at 6.25 AM OTA suggesting a dose-dependent
trend (Table 1). TOCO treatment appeared to have slightly
increased the basal GSH levels, but was unable to preserve
GSH levels after 24 h exposure to OTA. The GSH levels of
TOCO-treated cells decreased to the same extent as in
solvent-treated cells after exposure to OTA. Table 1 shows
that NAC treatment resulted in significantly higher GSH
levels after 24 h incubation with 6.25 AM OTA as compared
to solvent- and TOCO-treated cells, although this effect was
only significant as compared to TOCO-treated cells (Table
1). Taken together, these results illustrate that NAC treat-
ment preserved GSH levels in OTA-exposed PT- and LLC-
PK1 cells. This protective effect by NAC treatment was
more pronounced in PT cells as compared to NAC-treated
LLC-PK1 cells.
Fig. 3. Formation of 8-oxoguanine adducts in OTA-exposed LLC-PK1 cells. (A and B) LLC-PK1 cells were exposed for 1 h to solvent (panel A) or 2 mM
methylene blue (Pos Control) (panel B) followed by 30 min exposure to ambient light. Formation of 8-oxoguanine was assessed using the Biotrin oxyDNA
assay kit as described in the Materials and Methods section. (C and D) LLC-PK1 cells were exposed for 24 h to solvent (panel C) or 15 AM OTA (panel D) for
24 h and assessed for 8-oxoguanine formation. (E and F) Cells were treated with 4 mM NAC for 24 h before 24 h exposure to solvent (panel E) or 15 AM OTA
(panel F). The fixed cultures were then assayed for the formation of 8-oxoguanine adducts. The arrows indicate representative 8-oxoguanine positive cells. The
presented micrographs were taken from representative areas from one of two independent experiments. Original magnification:  20.
G.J. Schaaf et al. / Biochimica et Biophysica Acta 1588 (2002) 149–158 155
3.6. OTA-induced oxidative DNA damage
Fig. 3 shows the formation of 8-oxoguanine in LLC-PK1
cells after treatment with OTA, as assessed with the Biotrin
OxyDNA assay. The 8-oxoguanine adduct is a sensitive
marker of DNA base damage caused by oxygen free radicals
[24,29] and was detected in oxidant-treated cell cultures
using the same assay [30,31].
Panel A and B show the effect of methylene blue (MB)
treatment in combination with ambient light, which was
used as positive control. The combination of visible light
and MB is known to generate primarily 8-oxoguanine
adducts [27]. Panel A shows background staining, while
after 30 min, treatment with 2 mM MB clearly increased the
number of positively stained cells. This indicates that LLC-
PK1 cells respond to MB treatment by an increase in 8-
oxoguanine formation.
In contrast, exposure of LLC-PK1 cells for 4 h to 15 AM
OTA did not result in the formation of 8-oxoguanine
adducts (data not shown), which is in agreement with the
absence of ROS response below 25 AM OTA after 4 h
incubation (Fig. 1B).
Exposure of LLC-PK1 cells to 15 AM OTA (panel D) for
24 h resulted in a clear increase in 8-oxoguanine adduct
formation as compared to the solvent-treated cells (panel C).
This concentration of OTA found to induce oxidative DNA
damage was comparable to those elevating ROS levels
significantly in 24 h (Fig. 1B; 12.5 AM).
Pre-treatment of LLC-PK1 cells with NAC resulted in a
slight reduction in the level of background staining as
compared to solvent-treated controls (panel E vs. C). How-
ever, treatment of the cells with 4 mM NAC to 15 AM OTA
prevented the formation of 8-oxoguanine adducts (panel F),
suggesting that the observed OTA-induced 8-oxoguanine
formation was ROS-dependent.
4. Discussion
Previous studies implicate oxidative pathways in the
toxicity of OTA [5,15,16,18,32,33]. The present study was
conducted to investigate the role of oxidative stress in the
diverse toxic responses of renal tubular cells following
exposure to this mycotoxin.
Exposure of primary PT- and LLC-PK1 cells to OTA
increased the ROS levels in a concentration- and time-
dependent manner. Interestingly, OTA-induced ROS pro-
duction preceded the loss of cell viability particularly in
LLC-PK1 cells, indicating that the ROS response may
contribute to the OTA-induced cytotoxicity and is not a
consequence of it. This assumption is supported by the
observation that NAC treatment completely protected cells
against the OTA-induced loss of viability. Previous studies
in rodents exposed to OTA show that several anti-oxidants
(e.g. SOD and catalase) also provide protection in vivo
[5,34].
The ROS-detecting probe, H2DCF-DA, detects a wide
range of ROS species including O2
 , H2O2 and OH [35].
Lipid peroxides, although at a slow rate and in the presence
of lipoxygenase or Fe2 + , were also shown to oxidize this
probe [35]. The effects of different anti-oxidants, including
TOCO and NAC in the present study, superoxide dismutase
and catalase in previous studies [5], indicate that more than
one ROS might be involved in the observed oxidative stress
following OTA exposure.
TOCO is a chain-braking anti-oxidant, particularly effec-
tive in scavenging peroxyl and alkoxyl radicals, thus pre-
venting the propagation of LPO [23,36]. The lack of
cytoprotection by TOCO observed in PT and LLC-PK1
cells suggests that LPO contributes only marginally to the
cytotoxicity of OTA. This seems to be in contrast to
previous studies suggesting LPO as possible mechanism
of OTA toxicity [16,17]. However, our findings are in
agreement with the conclusion of Aleo et al. [37] that
despite the fact that OTA stimulates LPO apparently pre-
ceding cell death, this does not appear to contribute to OTA-
induced proximal tubular cell death. Interestingly, the latter
study also showed that OTA inhibits site I and II mitochon-
drial respiration and the authors concluded that OTA tox-
icity in renal PTs was related to mitochondrial dysfunc-
tioning [37]. It remains to be established, however, if
oxidative stress, in particular LPO, is involved in the
reported loss of mitochondrial function.
Another indication of OTA-related oxidative stress is
provided by the observed depletion of the cellular GSH
pool in the tubular cells following 24 h exposure to OTA.
TOCO treatment did not preserve GSH levels, while pre-
incubation with NAC apparently prevented GSH levels to
decrease below critical levels following exposure to OTA.
Prevention of OTA-induced loss of GSH by NAC was most
pronounced in PT cells, as compared to the modest protec-
tion observed in LLC-PK1 cells. This also corresponds to
the relatively greater protective effect of NAC in PT cells on
the OTA-mediated ROS response and loss of viability. The
quantitative differences of NAC treatment in the two renal
cell types may be explained by a decreased ability of the
LLC-PK1 cells to transport and accumulate NAC. For
instance, LLC-PK1 are shown to lack the organic anion
transport system [22], while we have shown previously that
rat PT cells functionally express this transporter [20].
Furthermore, the basal GSH levels in the two cell types
were substantially different. While NAC treatment resulted
in a 10-fold increase in the GSH levels of PT cells, it did not
increase the levels in LLC-PK1 cells. The high basal GSH
levels in LLC-PK1 cells most likely prevent a further
increase in response to NAC exposure by feedback inhib-
ition of gamma-glutamylcysteine synthetase, the rate-limit-
ing enzyme in GSH synthesis (for a review, see Ref. [38]).
In addition to the anti-oxidative effect of NAC and GSH,
the protective effect of NAC may be explained by the
nucleophilicity of GSH. Covalent binding of OTA to GSH
could inactivate the mycotoxin and promote its excretion
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from the tubular cell. Our results, therefore, point toward a
central role for GSH in the protection against OTA-induced
cellular toxicity.
We are the first to show that OTA induces the formation
of 8-oxoguanine in vitro, providing unequivocal evidence of
oxidative DNA damage. Oxidative base modifications may
result in mutations, whereas oxidation of deoxyribose moi-
eties may induce base release or DNA strand breaks (Ref.
[24] and references therein). Singlet oxygen selectively
reacts with guanine and predominantly forms 8-oxoguanine,
which is also one of the products formed after attack of
DNA by the hydroxyl radical [24,27].
In contrast, Gautier et al. [39] found no evidence for 8-
oxoguanine formation in rats treated with OTA (up to 2 mg/
kg body wt). The latter authors ascribe the discrepancy
between the generation of ROS in vitro and in vivo and the
resultant oxidative damage to the protective activity of GSH
and TOCO. Furthermore, those authors suggest that the
maximal plasma concentrations (15 AM) were below the
minimal OTA concentration (30 AM) required to induce
LPO in vitro and were consequently too low to induce 8-
oxoguanine formation in the rats.
Formation of 8-oxoguanine adducts occurred in a time-
dependent manner, which correlates well with the OTA-
induced production of ROS in these cells. Using the same
method as described in this study, Morin et al. [30,31]
showed the formation of 8-oxoguanine in cell cultures
treated with pro-oxidants. The OTA concentrations elevat-
ing the ROS levels and inducing the formation of 8-
oxoguanine were of the same order of magnitude. Recently,
Griffith [38] showed that OTA in the presence of Fe(III)-
porphyrin facilitates single-strand cleavage of supercoiled
plasmid DNA through the production of ROS (i.e. hydroxyl
radical HOS). The author proposes that OTA is oxidized to a
(hydro-) quinone. Quinones are known to redox cycle, thus
creating free radicals that bind covalently to a variety of
cellular macromolecules [40]. The formation of the (hydro-)
quinone of OTA implicates the reported involvement of
oxidative metabolism in the genotoxicity of OTA [41] and
could help to explain the previously described CYP450-
dependent mutagenicity of OTA and its metabolites [42].
Redox cycling causes the oxidation of reducing equivalents
in the cell, including GSH, and may thus contribute to the
observed depletion of GSH in the present study. Moreover,
Gautier et al. [43] have shown that most, if not all, of the
DNA adducts attributed to OTA and its metabolites do not
contain an OTA-moiety, further implicating oxidative stress
as important determinant in the OTA-induced DNA damage.
OTA and its metabolites have also been observed to induce
the formation of DNA adducts in rats and mice [34,44–46].
Interestingly, DNA adduct formation was reduced by pre-
treatment of mice with vitamins A, C and E, indicating the
involvement of oxidative stress in OTA-mediated DNA
damage [46].
The results of the present study show that OTA induced a
comparable response in the two PT cell models, the primary
PT- and the continuous LLC-PK1 cells. In addition, the
effects of TOCO and NAC on the OTA-mediated toxicity
were similar and differed only quantitatively. Particularly,
NAC showed a more potent protection in PT cells that can
be explained by its more pronounced effect on the GSH
levels in the primary cells. This suggests that the primary PT
cells are slightly less sensitive to the actions of OTA, as
judged by the lower maximal ROS response, the higher IC50
and the more potent NAC protection in the primary PT cells.
In conclusion, cultured renal tubular cells respond to
OTA exposure by elevation of ROS levels, depletion of
GSH levels and an increase in oxidative DNA damage,
which are indicators of oxidative stress. Taking our results
obtained with TOCO and NAC into account, it may be
hypothesized that the OTA-induced oxidative stress contrib-
utes to both the DNA damage and cytotoxicity. The effects
of TOCO indicate that OTA-induced LPO does not contrib-
ute profoundly to the observed loss of cell viability. The
strong protective effect of GSH indicates that oxidative-
stress-related protein damage is a major determinant in
OTA-mediated toxicity. To which extent the ROS formation
contributes to other toxic effects, in particular by disrupting
protein synthesis, affecting intracellular calcium handling,
or inducing mitochondrial dysfunctioning etc., requires
further exploration. Furthermore, OTA-related ROS forma-
tion may induce epigenetic effects.
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